Robert Wesolowski, MD, is a medical oncologist at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) in Columbus, Ohio. His clinical practice focuses on breast cancer. He joined Ohio State in 2010 and provides care for patients across all stages of invasive breast cancer. Dr. Wesolowski’s research interests include breast cancer immunology—particularly myeloid-derived suppressor cells (MDSCs)—and early-phase clinical trials of novel therapeutics. He coordinates phase I solid tumor trials, serves as a local principal investigator on several studies, and participates in precision oncology efforts through the institution’s Precision Medicine Clinic. He has authored and co-authored peer-reviewed publications on MDSCs and immunotherapy strategies in breast cancer and has contributed to work informing the use of biomarkers and immune checkpoint inhibitors in select breast cancer populations. In recognition of his patient-centered care, he was selected for the 2024 OSUCCC Physician Patient Champion Award.
Attending Physician
Medical School
Residency
Fellowship